biotech insider buys
biotech insider buys Articles
As January wound to a close, beneficial owners, executives, and other insiders took advantage of public offerings of stock at these biotech companies.
Published:
As the year got underway, biotechs were in focus among the notable insider buying, especially in two companies focused on treatments for the eye.
Published:
As the year wound to a close, the most notable insider buying was focused on biotech stocks, but an oil and gas company CEO also returned to the buy window.
Published: